Clearview RSV

Clearview RSV

Clearly different
Clearview’s patented innovative technology provides highly sensitive and
specific tests for Respiratory Syncytial Virus (RSV).

• Rapid Response: 4 easy steps,result in 15 minutes.
• Simplicity: CLIA waived,easy-to-use test requires no training.
• Reliability: Built-in control ensures accuracy.
• Flexibility: Multiple sample types — nasopharyngeal swabs
  or aspirates.

Clearly better
Clearview RSV is designed to aid in the rapid diagnosis in children less than
6 years and adults over age 60.

• Shortens the course of illness.
• Reduces severity of symptoms.
• Reduces the spread of virus to others.
• Reduces the risk of more serious illness in young children
  and elderly patients.

Clearview RSV

Rapid technology
provides direct
detection of Group A
Streptococcal Antigen.